Morris-Thurgood J, Cowell R, Paul V, Kalsi K, Seymour A M, Ilsley C, Mitchell A, Khaghani A, Yacoub M
Department of Cardiology, Harefield Hospital, Middlesex, London, England.
Circulation. 1994 Nov;90(5):2342-7. doi: 10.1161/01.cir.90.5.2342.
Heterotopic cardiac transplantation is a valuable surgical technique that maximizes the use of donor organs. However, recipient heart function may decline steadily postoperatively with resulting clinical deterioration. Paced linkage has the potential of reducing afterload and enhancing coronary flow of both hearts, thereby improving recipient- and donor-heart function. This may have long-term as well as short-term benefits.
The study was performed on 11 heterotopic transplant recipients. The two hearts were linked with a pacemaker (paced linkage) to produce recipient heart systole during different periods of donor-heart diastole. The recipient ventricular contraction was timed to occur during early, mid, and late diastole of the donor heart. Hemodynamic baseline measurements were compared with the optimal counterpulsated data. Paced linkage produced significant improvements in total cardiac output, 5.0 +/- 0.9 compared with baseline 4.5 +/- 0.8 L/min (P = .021); recipient coronary sinus flow, 278 +/- 145 versus 186 +/- 108 mL/min (P = .022); and aortic systolic pressure, 135 +/- 27 versus 123 +/- 27 mm Hg (P = .005). There was an overall improvement in systolic ventricular performance in the recipient heart when pace linked, as evidenced by a significant increase in left ventricular systolic pressure of 118 +/- 36 compared with the baseline value of 108 +/- 33 mm Hg (P = .016), an increase in ejection period from 174 +/- 30 versus 203 +/- 48 (P = .046), and a decrease in the pre-ejection period of 147 +/- 37 when paced versus 181 +/- 39 milliseconds (P = .013). The metabolic studies showed a significant decrease in hypoxanthine release from a baseline level of 0.4 mumol/L to a paced value of -0.06 mumol/L (P = .002); these very low values would suggest that there is no evidence of ischemia. Hemodynamic changes in the donor heart included a significant reduction in the left ventricular end-diastolic pressure from 6.8 +/- 4.4 versus baseline of 10.5 +/- 5.8 mm Hg (P = .029) and in maximum -dP/dT from 3.2 +/- 1.7 versus baseline of 2.1 +/- 1.1.
Paced linkage after heterotopic cardiac transplant produces significant functional improvements in both hearts. Permanent pacemaker implantation may sustain these acute benefits and prevent the premature deterioration of the recipient heart.
异位心脏移植是一种重要的外科技术,可最大限度地利用供体器官。然而,术后受者心脏功能可能会持续下降,导致临床病情恶化。起搏连接有可能降低后负荷并增加双心的冠状动脉血流,从而改善受者和供者心脏的功能。这可能具有短期和长期益处。
对11例异位移植受者进行了研究。通过起搏器将两颗心脏连接起来(起搏连接),以便在供体心脏舒张的不同时期产生受者心脏收缩。将受者心室收缩安排在供体心脏舒张的早期、中期和晚期发生。将血流动力学基线测量值与最佳反搏数据进行比较。起搏连接使心输出总量显著改善,与基线值4.5±0.8L/分钟相比为5.0±0.9(P = 0.021);受者冠状窦血流,分别为278±145与186±108mL/分钟(P = 0.022);以及主动脉收缩压,分别为135±27与123±27mmHg(P = 0.005)。起搏连接时,受者心脏的收缩期心室功能总体得到改善,表现为左心室收缩压显著升高,从基线值108±33mmHg升至118±36mmHg(P = 0.016),射血期从174±30增加至203±48(P = 0.046),起搏时射血前期从181±39毫秒降至147±37毫秒(P = 0.013)。代谢研究显示,次黄嘌呤释放量从基线水平0.4μmol/L显著降至起搏值-0.06μmol/L(P = 0.002);这些极低的值表明没有缺血迹象。供体心脏的血流动力学变化包括左心室舒张末期压力从基线的10.5±5.8mmHg显著降至6.8±4.4mmHg(P = 0.029),以及最大-dP/dT从基线的2.1±1.1降至3.2±1.7。
异位心脏移植后进行起搏连接可使双心功能显著改善。植入永久性起搏器可能维持这些急性益处,并防止受者心脏过早恶化。